Rapport Therapeutics, Inc. RAPP Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s software and technology licenses, net?
- Rapport Therapeutics, Inc. (RAPP) reported software and technology licenses, net of $1.06M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s software and technology licenses, net changed year-over-year?
- Rapport Therapeutics, Inc.'s software and technology licenses, net increased by 400.9% year-over-year, from $211K to $1.06M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s software and technology licenses, net?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s software and technology licenses, net has grown at a 33.7% compound annual growth rate (CAGR), from $551K to $985K.